What happened
BioNote filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$25.6M (+12.23% year on year), operating profit of US$5.95M (+33.21% year on year) and net income of US$6.38M (−89.27% year on year).
These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.
| Revenue | US$25.6M |
|---|---|
| Revenue vs a year earlier | +12.23% |
| Operating profit | US$5.95M |
| Net income | US$6.38M |
| Period | Q2 2026 (consolidated) |
| Filed | 2026-08-06, Operating results (consolidated) (preliminary) (fair disclosure) |
| Source | DART rcept 20260806800153 → open original filing |
Source: DART. Information only, not investment advice.